Cannabinoid Antagonists

Cannabinoid Antagonist is a pharmacological agent that belongs to the class of receptor antagonists and is specifically characterized by its ability to bind to cannabinoid receptors without activating them, thereby blocking or inhibiting the effects of cannabinoid agonists.

1.1K

Publications

91.8K

Citations

4.5K

Authors

996

Institutions

Publications per year

2017–2026

136

Authors

4.5K

  1. AM
    Alexandros Makriyannis

    Northeastern University, United States

    43 publications · 4.5K citations

    32

    h-index

  2. GK
    George Kunos

    National Institute on Alcohol Abuse and Alcoholism, United States

    32 publications · 4.4K citations

    29

    h-index

  3. VD
    Vincenzo Di Marzo

    National Research Council, Italy

    32 publications · 3.2K citations

    26

    h-index

  4. RG
    Roger G. Pertwee

    University of Aberdeen, United Kingdom

    29 publications · 3.6K citations

    25

    h-index

  5. BR
    Billy R. Martin

    Virginia Commonwealth University Medical Center, United States

    29 publications · 3K citations

    24

    h-index

1–5 of 4.5K

Venues

  1. British Journal of Pharmacology

    BJP · 125 publications · 11.8K citations

    67

    h-index

  2. 47

    h-index

  3. Journal of Medicinal Chemistry

    39 publications · 2.6K citations

    32

    h-index

  4. European Journal of Pharmacology

    EJP · 41 publications · 2.6K citations

    29

    h-index

  5. Journal of Neuroscience

    30 publications · 5.2K citations

    29

    h-index

1–5